Intuitive Surgical's CEO Shares Optimistic Outlook on Q1 2024 Performance
Friday, 19 April 2024, 01:15
Intuitive Surgical's Strong Q1 2024 Performance
Intuitive Surgical reported solid growth in procedures and capital placements for Q1 2024, highlighted by significant milestones achieved across various platforms.
Key Highlights:
- 16% growth in procedures compared to a strong Q1 '23
- Placement of 313 da Vinci systems, including new platforms like da Vinci 5 and Ion
- Improved supply constraints for Ion catheters with FDA clearance for extended usage
CEO's Strategy for 2024: Intuitive Surgical prioritizes supporting new platform launches, surgeon adoption, and product quality to drive overall growth and customer value.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.